Spoken Alpha
BAX
BAXTER INTERNATIONAL INC
Overview
BAXTER INTERNATIONAL INC is a Healthcare company operating in Medical Instruments & Supplies with a $10.38B market cap.
Most recent reported earnings: Q2 FY2026 (Jul 29, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-04-3016 Q&A exchanges
- Q4 FY2025Earnings2026-02-1224 Q&A exchanges
- Q3 FY2025Earnings2025-10-3013 Q&A exchanges
- Q2 FY2025Earnings2025-07-3111 Q&A exchanges
- Q1 FY2025Earnings2025-05-0119 Q&A exchanges
- Q4 FY2024Earnings2025-02-2021 Q&A exchanges
- Q3 FY2024Earnings2024-11-0821 Q&A exchanges
- Q2 FY2024Earnings2024-08-0626 Q&A exchanges
- Q1 FY2024Earnings2024-05-0215 Q&A exchanges
- Q4 FY2023Earnings2024-02-0817 Q&A exchanges
- Q3 FY2023Earnings2023-11-0223 Q&A exchanges
- Q2 FY2023Earnings2023-07-2714 Q&A exchanges
- Q1 FY2023Earnings2023-04-2722 Q&A exchanges
- Q4 FY2022Earnings2023-02-0913 Q&A exchanges
- Q3 FY2022Earnings2022-10-2718 Q&A exchanges
- Q2 FY2022Earnings2022-07-2814 Q&A exchanges
- Q1 FY2022Earnings2022-04-2816 Q&A exchanges
- Q4 FY2021Earnings2022-02-1723 Q&A exchanges
- Q3 FY2021Earnings2021-07-3026 Q&A exchanges
- Q2 FY2021Earnings2021-04-3027 Q&A exchanges
- Q1 FY2021Earnings2021-02-0517 Q&A exchanges
History
Earnings history
- Q2 FY20262026-07-29EPS— vs $0.37—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-07-29 | — | $0.37 | — | — | — | — | EODHD |
Source: EODHD. BAX reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks BAX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 60% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.96 | $0.66 | +45.6% | +7.0% | +7.5% |
| Q4 FY2026 | $1.33 | $0.98 | +35.8% | +3.1% | +4.7% |
| Q3 FY2026 | $1.34 | $0.93 | +44.5% | -3.6% | -0.9% |
| Q2 FY2026 | $1.47 | $1.00 | +46.5% | +6.8% | +9.2% |
| Q1 FY2025 | $1.28 | $0.92 | +38.9% | -0.3% | -1.0% |
| Q4 FY2025 | $1.30 | $0.96 | +35.9% | +2.3% | +2.1% |
| Q3 FY2025 | $1.31 | $0.91 | +44.0% | +7.9% | +9.7% |
| Q2 FY2025 | $1.56 | $1.09 | +43.4% | -3.0% | -4.9% |
| Q1 FY2024 | $1.46 | $1.08 | +35.2% | +0.7% | -1.5% |
| Q4 FY2024 | $1.44 | $1.00 | +43.6% | -0.2% | -0.8% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Andrew P HiderCEO10 mo3 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • guidance suspended Q2 FY2026
- Joel T GradeCFO9 mo10 callsCurrentSample
CFO since 2025 • 3/4 beats (75%) • last guidance raise Q1 FY2026
- Julie FosterPresident2 mono recorded callsCurrentSample
PRESIDENT since 2026 • 2/2 beats (100%) • last guidance cut Q2 FY2026
- Steven P WallacePresident2 mono recorded callsCurrentSample
PRESIDENT since 2026 • 1/2 beats (50%) • last guidance raise Q2 FY2026
- James TeaffPresident2 mono recorded callsCurrentSample
PRESIDENT since 2026 • 1/2 beats (50%) • guidance suspended Q3 FY2026
- Alok SonigPresident9 mono recorded callsCurrentSample
PRESIDENT since 2025 • 2/4 beats (50%) • last guidance cut Q3 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BAX.
$ curl https://api.spokenalpha.com/v1/companies/BAXFAQ
Frequently asked about BAX
Where can I find BAXTER INTERNATIONAL INC's (BAX) earnings call transcripts?
Spoken Alpha indexes BAX's earnings call transcripts at https://spokenalpha.com/companies/BAX. Each call links to attributed speakers and parsed analyst Q&A. BAXTER INTERNATIONAL INC's own investor relations page is at https://investor.baxter.com/investors/investor-overview/default.aspx.
When was BAXTER INTERNATIONAL INC's most recent earnings call?
BAXTER INTERNATIONAL INC (BAX) held its most recent earnings call on 2026-04-30, covering fiscal Q1 2026.
What sector is BAX in?
BAXTER INTERNATIONAL INC (BAX) operates in the Healthcare sector (Medical Instruments & Supplies industry).